Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLAKelly G. Paulson, Aude G. Chapuis|Nature Communications|2018Cited by 284
HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F. Krakow, Marie Bleakley, Corinne Summers et al.|Blood|2024Cited by 29
Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeuticsThomas M Schmitt, Aude G. Chapuis|Journal for ImmunoTherapy of Cancer|2026Cited by 0